Home › Trial NCT04171141
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
- Trial IDNCT04171141
- StatusTerminated
- PhasePhase 1
- Study typeInterventional
- SponsorPfizer
- Enrollment79
- Start date2019-11-19
- ConditionsGastrointestinal Tumors · Colorectal Adenocarcinomas · Gastric Adenocarcinomas · Esophageal Adenocarcinomas
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.